Describing flares: A mixed methods study comparing patient and clinician perspectives in systemic lupus erythematosus and other rheumatic diseases
Clicks: 1
ID: 325430
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #183 of 197 articles by views in Lara D. Veeken
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 197 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Objectives Systemic autoimmune rheumatic diseases (SARDs) relapse and remit, with periods of increased disease activity called “flares”. This study compared patient and clinician perspectives of flares. Methods Mixed-methods approach combining an international co-produced survey and in-depth interviews. SLE patients and clinicians rated statements about flares on Likert scales from “never” to “always”. Quantitative data were analysed using t-tests and ANOVA. Patient and clinician interviews were analysed thematically. Quantitative and qualitative analyses were triangulated by exploring converging, diverging and explanatory findings across the datasets. Results Qualitative (N = 31 SARD patients, N = 12 clinicians) and quantitative (N = 443 SLE patients, N = 258 clinicians) results indicated differential patient and clinician perspectives. The main themes identified were: characteristics/consequences of flares; recognition of flares; and treatment for flares (medical and/or self-management). Patients and clinicians had significantly different mean ratings for 12/17 flare statements. Notably, regarding flare onset, 39% of patients compared to 14% of clinicians said flares “often” or “always” started within minutes or hours (p < 0·001). We found differences in identification of flares, with patients rating “patient can tell” significantly higher than clinicians (p<·001), including awareness of prodromal symptoms. Clinicians were significantly more likely to think flares required increased (p = 0·005) or new (p<·001) medication. There was consensus about the impact of flares on wellbeing. Conclusion We highlight differences in how SARD patients and clinicians describe flares, notably related to onset, recognition and intervention. These differences challenge the prevailing reliance on clinician-derived disease activity measures and biomarkers for flare assessment, highlighting the need for integration of patient and clinician perspectives.
| Reference Key |
openalex_W7203823341
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Martha Piper, Alice Tunks, James A Bourgeois, Lucy Calderwood, David D’Cruz, Alessandra Bortoluzzi, Arjoon Arunasalam, Shaista Tayabali, Sydnae Taylor, Pratyasha Saha, Max Yates, Paige Hamilton-Conaty, Arvind Kaul, Melanie Sloan |
| Journal | Lara D. Veeken |
| Year | 2026 |
| DOI |
10.1093/rheumatology/keag443
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.